![Martin Lange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Lange
Direttore Tecnico/Scientifico/R&S presso
NOVO NORDISK A/S
Profilo
Martin Holst Lange is Director at Pharmacosmos A since 2023.
Dr. Lange is Chief Scientific Officer & Executive VP at Novo Nordisk A since 2002.
Formerly, Dr. Lange was Medical Director at Novo Nordisk, Inc. from 2006 to 2008.
Dr. Lange was Director at Beta Bionics, Inc. from 2017 to 2020.
Education includes two doctorates from the University of Copenhagen, conferred in 1997 and 2004.
Posizioni attive di Martin Lange
| Società | Posizione | Inizio |
|---|---|---|
| NOVO NORDISK A/S | Direttore Tecnico/Scientifico/R&S | 07/08/2025 |
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Direttore/Membro del Consiglio | 18/08/2023 |
Precedenti posizioni note di Martin Lange
| Società | Posizione | Fine |
|---|---|---|
| BETA BIONICS, INC. | Direttore/Membro del Consiglio | 20/02/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Direttore Tecnico/Scientifico/R&S | 01/01/2008 |
Formazione di Martin Lange
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
